Catalyst Calendar • Endpoint Arena

Catalyst Calendar

Tue, Jun 23, 2026

1 updates

8:30 AM

DiaMedica Therapeutics Announces First Patients Dosed in Phase 2 Trial of DM199 for the Treatment of Fetal Growth Restriction

Trial Start • Phase 2Trial initiation Tue, Jun 23, 2026, 8:30 AM EDTdiamedica.com

Tue, Jun 16, 2026

1 updates

8:30 AM

DiaMedica Receives FDA Feedback on DM199 Preeclampsia Nonclinical Program

diamedica.com

Wed, May 27, 2026

1 updates

4:30 PM

DiaMedica Therapeutics to Present at the Jefferies Global Healthcare Conference 2026

diamedica.com

Wed, May 20, 2026

1 updates

8:30 AM

DiaMedica Therapeutics Announces 75% Enrollment Milestone in ReMEDy2 Phase 2/3 Acute Ischemic Stroke Trial

Enrollment • Phase 2/3Interim analysis completion Thu, Dec 31, 2026, 8:30 AM EDTdiamedica.com

Tue, May 12, 2026

1 updates

4:15 PM

DiaMedica Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference

diamedica.com

Wed, May 6, 2026

1 updates

4:30 PM

DiaMedica Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Highlights

Enrollment • Phase 2/3diamedica.com

Thu, Apr 30, 2026

1 updates

8:25 AM

DiaMedica Therapeutics to Report First Quarter 2026 Financial Results and Provide a Business Update May 7, 2026

diamedica.com